Loading clinical trials...
Loading clinical trials...
Dose-Proportionality and Intra-Individual Variability of Intracellular Tenofovir Diphosphate and Emtricitabine Triphosphate In Healthy Volunteers
Conditions
Interventions
Emtricitabine/tenofovir
Locations
2
United States
Johns Hopkins University
Baltimore, Maryland, United States
University of North Carolina, Chapel Hill
Chapel Hill, North Carolina, United States
Start Date
January 1, 2011
Primary Completion Date
October 1, 2011
Completion Date
October 1, 2011
Last Updated
March 25, 2025
NCT01875588
NCT06857071
NCT06598397
NCT06627764
NCT07509853
NCT05384145
Lead Sponsor
HIV Prevention Trials Network
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions